177 related articles for article (PubMed ID: 23451743)
1. Making the diagnosis of frontotemporal lobar degeneration.
Bigio EH
Arch Pathol Lab Med; 2013 Mar; 137(3):314-25. PubMed ID: 23451743
[TBL] [Abstract][Full Text] [Related]
2. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.
Seo SW; Thibodeau MP; Perry DC; Hua A; Sidhu M; Sible I; Vargas JNS; Gaus SE; Rabinovici GD; Rankin KD; Boxer AL; Kramer JH; Rosen HJ; Gorno-Tempini ML; Grinberg LT; Huang EJ; DeArmond SJ; Trojanowski JQ; Miller BL; Seeley WW
Neurology; 2018 Mar; 90(12):e1047-e1056. PubMed ID: 29453245
[TBL] [Abstract][Full Text] [Related]
3. Plasma proteome profiling identifies changes associated to AD but not to FTD.
Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
5. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.
Boxer AL; Garbutt S; Seeley WW; Jafari A; Heuer HW; Mirsky J; Hellmuth J; Trojanowski JQ; Huang E; DeArmond S; Neuhaus J; Miller BL
Arch Neurol; 2012 Apr; 69(4):509-17. PubMed ID: 22491196
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
7. New insights into biological markers of frontotemporal lobar degeneration spectrum.
Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging for frontotemporal lobar degeneration].
Oba H; Tokumaru A
Brain Nerve; 2009 Nov; 61(11):1269-73. PubMed ID: 19938683
[TBL] [Abstract][Full Text] [Related]
11. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathology of frontotemporal dementia].
Murayama S
Rinsho Shinkeigaku; 2008 Nov; 48(11):998. PubMed ID: 19198143
[TBL] [Abstract][Full Text] [Related]
13. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
[TBL] [Abstract][Full Text] [Related]
14. [History and classification of frontotemporal lobar degeneration].
Okamoto K
Brain Nerve; 2009 Nov; 61(11):1203-8. PubMed ID: 19938676
[TBL] [Abstract][Full Text] [Related]
15. Review: Neuropathology of non-tau frontotemporal lobar degeneration.
Neumann M; Mackenzie IRA
Neuropathol Appl Neurobiol; 2019 Feb; 45(1):19-40. PubMed ID: 30357887
[TBL] [Abstract][Full Text] [Related]
16. [Brain functional imaging of frontotemporal lobar degeneration].
Nakano S; Matsuda H
Brain Nerve; 2009 Nov; 61(11):1275-84. PubMed ID: 19938684
[TBL] [Abstract][Full Text] [Related]
17. Novel CSF biomarkers for frontotemporal lobar degenerations.
Hu WT; Chen-Plotkin A; Grossman M; Arnold SE; Clark CM; Shaw LM; McCluskey L; Elman L; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
Neurology; 2010 Dec; 75(23):2079-86. PubMed ID: 21048198
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
19. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
Oeckl P; Steinacker P; Feneberg E; Otto M
J Neurochem; 2016 Aug; 138 Suppl 1():184-92. PubMed ID: 27186717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
